Company Overview

WNDM Medical Inc. is a biotechnology innovator focused on products that work with the body’s ability to heal and remodel tissues. Innovation isn't born, it's bred. That’s why our approach to product development merges science and technology with the goal of creating innovative, safe and cost-effective products for the ever-changing surgery landscape. With our No. 1 goal of improving patient outcomes, we develop, market and distribute biotechnology products to physicians, hospitals and clinics in the health care market.

In addition to HemaQuell® Resorbable Bone Hemostat, WNDM’s primary focus is the distribution of its unique, patented product CellerateRX® Surgical Activated Collagen® Adjuvant, which is FDA-cleared for all surgical and traumatic wounds except third-degree burns. 

 

Our Leadership

To review a complete list of Wound Management Technologies' leadership and members of the board, click here.